The Constitution and vaccinations

World of DTC Marketing

The government has latitude to protect citizens from deadly conditions, especially when the science supporting vaccination is so clear” With respect to children, parents do not have carte blanche. The post The Constitution and vaccinations. in the news Vaccinations & the law

Is it time for vaccination mandates?

World of DTC Marketing

29 percent of Americans said they were unlikely to get vaccinated — up from 24 percent three months earlier. Most workers do not want their own employer to require vaccination, including the vast majority of unvaccinated workers (92%). The post Is it time for vaccination mandates?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Responding to outbreak, Moderna starts early work on monkeypox vaccine

Bio Pharma Dive

began releasing supplies of an approved Bavarian Nordic shot, Moderna said it's beginning development of its own vaccine against the virus One day after the U.S.

Rethinking the rabies vaccine

Scienmag

Biology rabies Rethinking vaccineLA JOLLA—Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don’t realize they’ve been exposed until it is too late.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Optimism on Pfizer COVID vaccine is unwarranted

World of DTC Marketing

You need to ask yourself why in the hell Pfizer’s CEO would say that their vaccine is 90% effective when there is a lot more testing and review of data needed. However, there’s still a long way to go before researchers can be certain that this vaccine is indeed as effective as promised.

Profiteering off a Covid vaccine

World of DTC Marketing

SUMMARY: Johnson & Johnson and AstraZeneca publicly committed to not profiting off their products during the pandemic; Pfizer and Moderna made no such pledge and are already planning ways to make more money from their Covid vaccines. The post Profiteering off a Covid vaccine.

Mandating vaccinations is the right decision

World of DTC Marketing

The government has the latitude to protect citizens from deadly conditions, especially when the science supporting vaccination is so clear” We, as a nation, can not allow ignorance and stupidity to endanger us all. were for people who skipped out on getting vaccinated.

J&J ends hepatitis B, HPV vaccine work with Bavarian Nordic

Bio Pharma Dive

The companies' hepatitis B program never reached clinical testing, while J&J said it would no longer develop an HPV vaccine because of the "widespread uptake" of effective shots from other companies

The Covid-19 vaccine numbers game

World of DTC Marketing

SUMMARY: The numbers game for COVOD-19 vaccine makers has started but what most of the public, and the media, don’t understand is that the preliminary numbers don’t mean a damn thing until they are peer-reviewed. As I See It COVID Vaccine

FDA advisers back Novavax's latecomer COVID-19 vaccine

Bio Pharma Dive

Outside experts debated the shot's safety profile and its efficacy versus the omicron variant but ultimately supported the vaccine, which is made using more traditional technology than Pfizer's and Moderna's

Pfizer, BioNTech bet mRNA can make a better shingles vaccine

Bio Pharma Dive

The pharma company, already partnered with BioNTech on vaccines for COVID-19 and influenza, will pay $225 million upfront to further expand its work with the German biotech

Researchers propose a new live-attenuated influenza A vaccine approach

Scienmag

A promising strategy to reduce the impact of viral infectious diseases, such as influenza, is the use of attenuated, live viruses as vaccines. Medicine & Health approach influenza liveattenuated propose researchers vaccine

Covid vaccine profits and the strain on supply channels

World of DTC Marketing

SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others.

Vaccine from Medicago, GSK protective against COVID-19 in large study

Bio Pharma Dive

The vaccine, which Medicago plans to soon submit to Canadian regulators, would be the first of its type, though supply appears likely to be limited

Monkeypox: The vaccine landscape

BioPharma Reporter

Interest in vaccines against monkeypox is growing as the outbreak spreads around the world. The arsenal includes existing smallpox vaccines and potential new monkeypox specific mRNA vaccines.

A 3D printed vaccine patch offers vaccination without a shot

Scienmag

Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot. Social & Behavioral Science offers patch printed shot vaccination vaccine

Consumers fall into three COVID-19 vaccine adoption segments

World of DTC Marketing

(Mckinsey) Much of the prevailing market research on COVID-19 vaccination frames sentiment as “likely,” “unlikely,” or “neutral.” Their research has found that consumers’ attitudes towards receiving a COVID-19 vaccine fall into three primary segments. in the news COVID Vaccine

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Bio Pharma Dive

The company estimated revenue from its COVID-19 vaccine and antiviral pill Paxlovid will total $54 billion this year. Curiously, its stock fell by more than 5

Sales 229

What DTC marketers can learn from people who refuse a COVID vaccination

World of DTC Marketing

SUMMARY: Even though the Delta variant of COVID is highly contagious, people are still choosing not to get vaccinated. Concerns about safety, fear of unknown side effects, and misinformation about COVID-19 are some reasons why people may not accept the vaccine.

Moderna follows Pfizer in beginning trial of omicron vaccine

Bio Pharma Dive

New data, meanwhile, help affirm the benefit of a third dose of Moderna's current vaccine The study will test a version of the biotech's COVID-19 shot that's tailored to the infectious variant.

Trials 251

J&J's coronavirus vaccine faces new US limits

Bio Pharma Dive

Days after the FDA strengthened safety warnings for the company's shot, a CDC panel recommended Pfizer's and Moderna's vaccines be "preferred" over J&J's

Tracking the FDA's meeting on Pfizer's vaccine for kids

Bio Pharma Dive

Outside experts are reviewing Pfizer's application for emergency authorization of its vaccine in 5- to 11-year-olds. Follow their discussion with BioPharma Dive reporters live

Chinese drugmaker Clover says vaccine prevents COVID-19 in large trial

Bio Pharma Dive

Positive results from Clover's Phase 3 study could mean another coronavirus vaccine option for the many countries still grappling with short supplies

Trials 263

Vaccine makers move quickly to confront omicron threat

Bio Pharma Dive

Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant, which experts worry could more readily evade vaccine protection

What DTC marketers can learn from people who refuse vaccines

World of DTC Marketing

SUMMARY : Vaccine mandates are only going to get us so far when it comes to COVID immunity. The reasons for people refusing vaccines are both safety and side effect concerns, although politics plays a big part as well. As I See It COVID Vaccine

UTHealth Houston study: Flu vaccination linked to 40% reduced risk of Alzheimer’s disease

Scienmag

People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.

FDA grants full approval to Pfizer, BioNTech's coronavirus vaccine

Bio Pharma Dive

The long-awaited decision could strengthen the case for vaccine mandates as public health officials seek to boost rates of immunization amid a wave of COVID-19 cases

FDA places stricter limits on J&J's COVID-19 vaccine after review of rare side effect

Bio Pharma Dive

The agency is limiting use to adults who either can't or won't take another authorized vaccine after collecting more data on a rare and unusual clotting syndrome that has weighed on the shot's uptake

Unvaccinated people increase risk of SARS-CoV-2 for vaccinated people even when vaccination rates are high

Scienmag

Unvaccinated people threaten the safety of the vaccinated even when SARS-Cov-2 vaccination rates are high, according to a new modelling study published in CMAJ (Canadian Medical Association Journal) [link] “Many opponents of vaccine mandates have framed vaccine adoption as a matter of individual choice,” writes Dr. David Fisman, Dalla Lana School of Public Health, University of […].

UK authorizes AstraZeneca, Oxford coronavirus vaccine, but questions linger

Bio Pharma Dive

The first public vaccinations with AstraZeneca and Oxford’s shot will begin early in the New Year. But it’s still unclear how effective the vaccine is, or the best way to use it

UPS delivers coronavirus vaccines via temperature-controlled drone

Bio Pharma Dive

Drones have emerged as a speedy logistics option for time- and temperature-sensitive vaccine doses, potentially helping boost the availability of shots in rural areas

FDA advisers recommend Pfizer, Moderna COVID-19 vaccines for youngest children

Bio Pharma Dive

Independent experts unanimously supported use of both shots in children aged 6 months to 5 years old, clearing the way for an FDA decision

FDA authorizes Pfizer's coronavirus vaccine for younger teens

Bio Pharma Dive

The emergency clearance greatly expands the pool of people who can be vaccinated in the U.S. just as some states are beginning to report waning demand

Online sentiment about vaccines previews later vaccination rates, new Twitter study finds

Scienmag

Sentiments toward COVID-19 vaccines, whether positive or negative, previews subsequent vaccination rates, finds a study of related Twitter posts. Latest News finds online previews rates sentiment study Twitter vaccination VaccinesThe results offer new insights into the influence of social media on public health measures.

Pfizer set to double weekly production of coronavirus vaccine

Bio Pharma Dive

The drugmaker will use production lines at its plant in McPherson, Kansas to help fill vaccine vials, company CEO Albert Bourla said Friday

THE LANCET INFECTIOUS DISEASES: COVID-19 vaccines are estimated to have prevented 20 million deaths worldwide in the first year of the vaccine programme, modelling study finds

Scienmag

Peer-reviewed / Mathematical modelling First modelling study to quantify the impact of COVID-19 vaccines on a global scale estimates that 19.8 million deaths were prevented in the first year after vaccines were introduced (8 December 2020 – 8 December 2021). Latest News COVID19 deaths diseases estimated finds infectious Lancet million modelling prevented programme study vaccine Vaccines worldwide year

FDA authorizes J&J's one-shot coronavirus vaccine

Bio Pharma Dive

The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time

Moderna reveals first study results for seasonal flu vaccine

Bio Pharma Dive

Data from a small Phase 1 trial showed the biotech's vaccine spurred immune responses to four common strains, although they didn't appear significantly greater than an already available shot from Sanofi

Flu Vaccine vs. COVID-19 Vaccine

My Local Study

These differences also explain why vaccines are necessary for both the flu and COVID-19. Read more Flu Vaccine vs. COVID-19 Vaccine. The post Flu Vaccine vs. COVID-19 Vaccine appeared first on MyLocalStudy.com.

Moderna vaccine sales surpass expectations as company looks to fall boosters

Bio Pharma Dive

The trajectory of COVID-19 vaccine sales is now harder to predict amid questions about the rollout of additional doses and whether purchasing in the U.S.

Sales 229

Novavax says vaccine 90% effective against COVID-19 in large trial

Bio Pharma Dive

Highly anticipated results from a Phase 3 study testing the biotech company's shot showed it to be strongly protective and safe, a potential boon for the world's vaccination efforts

Trials 269

UK to start study testing Pfizer, AstraZeneca vaccines together

Bio Pharma Dive

The government-funded trial will evaluate the effects of mixing vaccines and varying timing between shots

Trials 219